Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	GPS	PKD1L1 ADGRG4 ADGRG6 ADGRF5	3.13e-05	36	94	4	PS50221
Domain	GPS	PKD1L1 ADGRG4 ADGRG6 ADGRF5	3.50e-05	37	94	4	IPR000203
Domain	ADAM_spacer1	ADAMTS1 ADAMTS9 ADAMTS18	2.03e-04	23	94	3	IPR010294
Domain	ADAM_spacer1	ADAMTS1 ADAMTS9 ADAMTS18	2.03e-04	23	94	3	PF05986
Domain	Peptidase_M12B_ADAM-TS	ADAMTS1 ADAMTS9 ADAMTS18	2.31e-04	24	94	3	IPR013273
Domain	DMAP_binding	DIP2A DIP2C	2.48e-04	5	94	2	PF06464
Domain	DMAP1-bd	DIP2A DIP2C	3.71e-04	6	94	2	IPR010506
Domain	DMAP_binding	DIP2A DIP2C	3.71e-04	6	94	2	SM01137
Domain	Arm_3	KPNA5 KPNA1	5.18e-04	7	94	2	PF16186
Domain	PKD	PKD1L1 SORCS2	5.18e-04	7	94	2	PF00801
Domain	Importing_su_alpha	KPNA5 KPNA1	5.18e-04	7	94	2	IPR024931
Domain	Arm_3	KPNA5 KPNA1	5.18e-04	7	94	2	IPR032413
Domain	IBB	KPNA5 KPNA1	5.18e-04	7	94	2	PF01749
Domain	MFS_dom	SLC2A2 SLC2A10 SLC22A13 SLC49A3 MFSD13A	5.81e-04	134	94	5	IPR020846
Domain	GPS	ADGRG4 ADGRG6 ADGRF5	6.60e-04	34	94	3	SM00303
Domain	GPCR_2_secretin-like_CS	ADGRG4 ADGRG6 ADGRF5	6.60e-04	34	94	3	IPR017983
Domain	IBB	KPNA5 KPNA1	6.88e-04	8	94	2	PS51214
Domain	GPS	ADGRG4 ADGRG6 ADGRF5	7.19e-04	35	94	3	PF01825
Domain	MetalloPept_cat_dom	ADAMTS1 ECE1 ADAMTS9 ADAMTS18	7.44e-04	81	94	4	IPR024079
Domain	-	ADAMTS1 ECE1 ADAMTS9 ADAMTS18	7.44e-04	81	94	4	3.40.390.10
Domain	MFS_sugar_transport-like	SLC2A2 SLC2A10 SLC22A13	7.82e-04	36	94	3	IPR005828
Domain	Sugar_tr	SLC2A2 SLC2A10 SLC22A13	7.82e-04	36	94	3	PF00083
Domain	ConA-like_dom	MID2 TRIM65 ADGRG4 ADGRG6 THBS4 ALK	8.38e-04	219	94	6	IPR013320
Domain	Importin-a_IBB	KPNA5 KPNA1	8.82e-04	9	94	2	IPR002652
Domain	PKD/Chitinase_dom	PKD1L1 SORCS2	8.82e-04	9	94	2	IPR022409
Domain	PKD	PKD1L1 SORCS2	8.82e-04	9	94	2	SM00089
Domain	Peptidase_M12B_N	ADAMTS1 ADAMTS9 ADAMTS18	9.89e-04	39	94	3	IPR002870
Domain	Pep_M12B_propep	ADAMTS1 ADAMTS9 ADAMTS18	9.89e-04	39	94	3	PF01562
Domain	DISINTEGRIN_1	ADAMTS1 ADAMTS9 ADAMTS18	1.07e-03	40	94	3	PS00427
Domain	G_PROTEIN_RECEP_F2_1	ADGRG4 ADGRG6 ADGRF5	1.07e-03	40	94	3	PS00649
Domain	GPCR_2_extracellular_dom	ADGRG4 ADGRG6 ADGRF5	1.07e-03	40	94	3	IPR001879
Domain	Reprolysin	ADAMTS1 ADAMTS9 ADAMTS18	1.07e-03	40	94	3	PF01421
Domain	ARM_REPEAT	KPNA5 ARMC2 KPNA1	1.07e-03	40	94	3	PS50176
Domain	ADAM_MEPRO	ADAMTS1 ADAMTS9 ADAMTS18	1.07e-03	40	94	3	PS50215
Domain	DISINTEGRIN_2	ADAMTS1 ADAMTS9 ADAMTS18	1.07e-03	40	94	3	PS50214
Domain	G_PROTEIN_RECEP_F2_3	ADGRG4 ADGRG6 ADGRF5	1.07e-03	40	94	3	PS50227
Domain	ARM	KPNA5 ARMC2 KPNA1	1.07e-03	40	94	3	SM00185
Domain	Peptidase_M12B	ADAMTS1 ADAMTS9 ADAMTS18	1.07e-03	40	94	3	IPR001590
Domain	PTX	ADGRG4 ADGRG6	1.10e-03	10	94	2	SM00159
Domain	Disintegrin_dom	ADAMTS1 ADAMTS9 ADAMTS18	1.15e-03	41	94	3	IPR001762
Domain	Pentaxin-related	ADGRG4 ADGRG6	1.34e-03	11	94	2	IPR001759
Domain	Pentaxin	ADGRG4 ADGRG6	1.34e-03	11	94	2	PF00354
Domain	PKD	PKD1L1 SORCS2	1.34e-03	11	94	2	PS50093
Domain	PKD_dom	PKD1L1 SORCS2	1.34e-03	11	94	2	IPR000601
Domain	-	PKD1L1 SORCS2	1.34e-03	11	94	2	2.60.40.670
Domain	ZINC_PROTEASE	ADAMTS1 ECE1 ADAMTS9 ADAMTS18	1.51e-03	98	94	4	PS00142
Domain	Armadillo	KPNA5 ARMC2 KPNA1	1.71e-03	47	94	3	IPR000225
Domain	G_PROTEIN_RECEP_F2_2	ADGRG4 ADGRG6 ADGRF5	2.04e-03	50	94	3	PS00650
Domain	7tm_2	ADGRG4 ADGRG6 ADGRF5	2.04e-03	50	94	3	PF00002
Domain	MFS	SLC2A2 SLC2A10 SLC22A13 SLC49A3	2.16e-03	108	94	4	PS50850
Domain	Sugar/inositol_transpt	SLC2A2 SLC2A10	2.19e-03	14	94	2	IPR003663
Domain	SUGAR_TRANSPORT_2	SLC2A2 SLC2A10	3.24e-03	17	94	2	PS00217
Domain	GPCR_2_secretin-like	ADGRG4 ADGRG6 ADGRF5	3.43e-03	60	94	3	IPR000832
Domain	GPCR_2-like	ADGRG4 ADGRG6 ADGRF5	3.43e-03	60	94	3	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	ADGRG4 ADGRG6 ADGRF5	3.60e-03	61	94	3	PS50261
Domain	TSP_1	ADAMTS1 ADAMTS9 ADAMTS18	3.94e-03	63	94	3	PF00090
Domain	Pkinase_Tyr	EPHB2 TEX14 HASPIN ALK	4.10e-03	129	94	4	PF07714
Domain	TSP1	ADAMTS1 ADAMTS9 ADAMTS18	4.30e-03	65	94	3	SM00209
Domain	TSP1_rpt	ADAMTS1 ADAMTS9 ADAMTS18	4.30e-03	65	94	3	IPR000884
Domain	TSP1	ADAMTS1 ADAMTS9 ADAMTS18	4.30e-03	65	94	3	PS50092
Pubmed	Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics.	ADAMTS1 ADAMTS9 ADAMTS18	4.98e-06	12	100	3	25770910
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	ADAMTS1 VIRMA ADAMTS9 NYNRIN SORCS2 ALPK3	5.57e-06	153	100	6	10718198
Pubmed	Cloning, genomic organization and expression pattern of a novel Drosophila gene, the disco-interacting protein 2 (dip2), and its murine homolog.	DIP2A DIP2C	8.18e-06	2	100	2	12137943
Pubmed	Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma.	MTOR ALK	8.18e-06	2	100	2	25228590
Pubmed	Homocysteine metabolites impair the PHF8/H4K20me1/mTOR/autophagy pathway by upregulating the expression of histone demethylase PHF8-targeting microRNAs in human vascular endothelial cells and mice.	PHF8 MTOR	8.18e-06	2	100	2	39323294
Pubmed	Fluid shear stress induces Runx-2 expression via upregulation of PIEZO1 in MC3T3-E1 cells.	PIEZO1 RUNX2	8.18e-06	2	100	2	32181967
Pubmed	Ubiquitin ligase and signalling hub MYCBP2 is required for efficient EPHB2 tyrosine kinase receptor function.	EPHB2 MYCBP2	8.18e-06	2	100	2	38289221
Pubmed	Regulation of karyopherin α1 and nuclear import by mammalian target of rapamycin.	MTOR KPNA1	8.18e-06	2	100	2	22399302
Pubmed	Abnormal expressions of ADAMTS-1, ADAMTS-9 and progesterone receptors are associated with lower oocyte maturation in women with polycystic ovary syndrome.	ADAMTS1 ADAMTS9	8.18e-06	2	100	2	30446843
Pubmed	Sequence and functional analysis of GLUT10: a glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1.	SLC2A2 SLC2A10	8.18e-06	2	100	2	11592815
Pubmed	ADAMTS18 Deficiency Affects Neuronal Morphogenesis and Reduces the Levels of Depression-like Behaviors in Mice.	ADAMTS1 ADAMTS9 ADAMTS18	1.26e-05	16	100	3	30579834
Pubmed	DDiT4L promotes autophagy and inhibits pathological cardiac hypertrophy in response to stress.	DDIT4L MTOR	2.45e-05	3	100	2	28246202
Pubmed	Probing the specificity of binding to the major nuclear localization sequence-binding site of importin-alpha using oriented peptide library screening.	KPNA5 KPNA1	2.45e-05	3	100	2	20406804
Pubmed	CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1.	DIP2A DIP2C	2.45e-05	3	100	2	17236128
Pubmed	Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility.	SLC2A2 SLC2A10	2.45e-05	3	100	2	11247674
Pubmed	Importin alpha nuclear localization signal binding sites for STAT1, STAT2, and influenza A virus nucleoprotein.	KPNA5 KPNA1	2.45e-05	3	100	2	12740372
Pubmed	The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway.	DDIT4L MTOR	2.45e-05	3	100	2	15632201
Pubmed	Fam3c modulates osteogenic differentiation by down-regulating Runx2.	RUNX2 FAM3C	2.45e-05	3	100	2	27914282
Pubmed	[Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma].	MTOR ALK	2.45e-05	3	100	2	19176054
Pubmed	Elucidating the mechanism of IL-1β-Mediated Piezo1 expression regulation of chondrocyte autophagy and apoptosis via the PI3K/AKT/mTOR signaling Pathway.	PIEZO1 MTOR	2.45e-05	3	100	2	38134572
Pubmed	Homocysteine metabolites inhibit autophagy, elevate amyloid beta, and induce neuropathy by impairing Phf8/H4K20me1-dependent epigenetic regulation of mTOR in cystathionine β-synthase-deficient mice.	PHF8 MTOR	2.45e-05	3	100	2	37477632
Pubmed	Differential gene expression of ADAMTS-1, ADAMTS-9 and TIMP-3 in periodontitis.	ADAMTS1 ADAMTS9	2.45e-05	3	100	2	36093887
Pubmed	Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1 signaling.	ATP6V0A1 MTOR	2.45e-05	3	100	2	24468901
Pubmed	Mechanically activated ion channel Piezo1 contributes to melanoma malignant progression through AKT/mTOR signaling.	PIEZO1 MTOR	2.45e-05	3	100	2	36112948
Pubmed	Differentially regulated ADAMTS1, 8, and 18 in gastric adenocarcinoma.	ADAMTS1 ADAMTS18	2.45e-05	3	100	2	28814085
Pubmed	ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.	ADAMTS9 MTOR	2.45e-05	3	100	2	22907434
Pubmed	ADAMTS1, ADAMTS5, ADAMTS9 and aggrecanase-generated proteoglycan fragments are induced following spinal cord injury in mouse.	ADAMTS1 ADAMTS9	2.45e-05	3	100	2	23562508
Pubmed	mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression.	RUNX2 MTOR	2.45e-05	3	100	2	28686577
Pubmed	Expression analysis of genes encoding TEX11, TEX12, TEX14 and TEX15 in testis tissues of men with non-obstructive azoospermia.	TEX15 TEX14	4.89e-05	4	100	2	29932616
Pubmed	A nonconventional nuclear localization signal within the UL84 protein of human cytomegalovirus mediates nuclear import via the importin alpha/beta pathway.	KPNA5 KPNA1	4.89e-05	4	100	2	12610148
Pubmed	mTOR inhibition potentiates cytotoxicity of Vγ4 γδ T cells via up-regulating NKG2D and TNF-α.	KLRK1 MTOR	4.89e-05	4	100	2	27256566
Pubmed	Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18.	ADAMTS9 ADAMTS18	4.89e-05	4	100	2	16507336
Pubmed	Genetic determinants of circulating sphingolipid concentrations in European populations.	ATP10D FADS3	4.89e-05	4	100	2	19798445
Pubmed	The human and mouse repertoire of the adhesion family of G-protein-coupled receptors.	ADGRG4 ADGRG6 ADGRF5	7.98e-05	29	100	3	15203201
Pubmed	Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal.	KPNA5 KPNA1	8.14e-05	5	100	2	19961612
Pubmed	Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.	TRPC1 MTOR	8.14e-05	5	100	2	22446186
Pubmed	Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite.	KPNA5 KPNA1	8.14e-05	5	100	2	17981117
Pubmed	Identification of domains of ataxia-telangiectasia mutated required for nuclear localization and chromatin association.	KPNA5 KPNA1	8.14e-05	5	100	2	15929992
Pubmed	Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells.	ADAMTS1 ADAMTS9	8.14e-05	5	100	2	22562232
Pubmed	International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.	ADGRG4 ADGRG6 ADGRF5	1.18e-04	33	100	3	25713288
Pubmed	Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import.	KPNA5 KPNA1	1.22e-04	6	100	2	8551560
Pubmed	Retinoblastoma-binding Protein 4-regulated Classical Nuclear Transport Is Involved in Cellular Senescence.	KPNA5 KPNA1	1.22e-04	6	100	2	26491019
Pubmed	p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.	KPNA5 KPNA1	1.22e-04	6	100	2	2064827
Pubmed	Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.	KPNA5 KPNA1	1.22e-04	6	100	2	9548947
Pubmed	The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.	KPNA5 KPNA1	1.22e-04	6	100	2	9557700
Pubmed	A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.	KPNA5 KPNA1	1.22e-04	6	100	2	9603322
Pubmed	CNI-H0294, a nuclear importation inhibitor of the human immunodeficiency virus type 1 genome, abrogates virus replication in infected activated peripheral blood mononuclear cells.	KPNA5 KPNA1	1.22e-04	6	100	2	9593140
Pubmed	HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase.	KPNA5 KPNA1	1.22e-04	6	100	2	7585960
Pubmed	The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.	KPNA5 KPNA1	1.22e-04	6	100	2	8041786
Pubmed	The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes.	KPNA5 KPNA1	1.22e-04	6	100	2	8041734
Pubmed	HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.	KPNA5 KPNA1	1.22e-04	6	100	2	9303297
Pubmed	Inhibition of nuclear import by backbone cyclic peptidomimetics derived from the HIV-1 MA NLS sequence.	KPNA5 KPNA1	1.22e-04	6	100	2	11904219
Pubmed	Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.	KPNA5 KPNA1	1.22e-04	6	100	2	9918876
Pubmed	Rheb and mTOR regulate neuronal polarity through Rap1B.	RAP1B MTOR	1.22e-04	6	100	2	18842593
Pubmed	HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.	KPNA5 KPNA1	1.22e-04	6	100	2	7859280
Pubmed	Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.	KPNA5 KPNA1	1.22e-04	6	100	2	8529100
Pubmed	Proteolytic cleavage of versican during cardiac cushion morphogenesis.	ADAMTS1 ADAMTS9	1.22e-04	6	100	2	16691565
Pubmed	Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection.	KPNA5 KPNA1	1.22e-04	6	100	2	9008157
Pubmed	A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal.	KPNA5 KPNA1	1.22e-04	6	100	2	15037073
Pubmed	Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation.	KPNA5 KPNA1	1.22e-04	6	100	2	8876228
Pubmed	Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.	KPNA5 KPNA1	1.22e-04	6	100	2	7745752
Pubmed	Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.	KPNA5 KPNA1	1.22e-04	6	100	2	8659115
Pubmed	The mammalian SPD-2 ortholog Cep192 regulates centrosome biogenesis.	CEP192 NEDD1	1.22e-04	6	100	2	18207742
Pubmed	Galnt1 is required for normal heart valve development and cardiac function.	GALNT10 ADAMTS1 ADAMTS9	1.54e-04	36	100	3	25615642
Pubmed	The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.	ADAMTS1 ADAMTS9	1.70e-04	7	100	2	15599946
Pubmed	Active nuclear import and cytoplasmic retention of activation-induced deaminase.	KPNA5 KPNA1	1.70e-04	7	100	2	19412186
Pubmed	Endothelial deletion of ADAM17 in mice results in defective remodeling of the semilunar valves and cardiac dysfunction in adults.	ADAMTS1 ADAMTS9	1.70e-04	7	100	2	23354118
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	IFT172 CEP192 PHF8 CSMD3 VIRMA STRIP1 WDR47	1.80e-04	407	100	7	12693553
Pubmed	Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis.	ADAMTS1 ADAMTS9 ADAMTS18	1.81e-04	38	100	3	18267097
Pubmed	Novel human G protein-coupled receptors with long N-terminals containing GPS domains and Ser/Thr-rich regions.	ADGRG4 ADGRF5	2.27e-04	8	100	2	12435584
Pubmed	Nuclear translocation of hypoxia-inducible factors (HIFs): involvement of the classical importin alpha/beta pathway.	KPNA5 KPNA1	2.27e-04	8	100	2	18187047
Pubmed	BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells.	KPNA5 KPNA1	2.27e-04	8	100	2	26052702
Pubmed	Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm.	KPNA5 KPNA1	2.27e-04	8	100	2	20015032
Pubmed	Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.	KPNA5 KPNA1	2.27e-04	8	100	2	8552640
Pubmed	HIV-1 nuclear import: in search of a leader.	KPNA5 KPNA1	2.91e-04	9	100	2	10525473
Pubmed	HIV-1 infection requires a functional integrase NLS.	KPNA5 KPNA1	2.91e-04	9	100	2	11389849
Pubmed	Viral protein R regulates nuclear import of the HIV-1 pre-integration complex.	KPNA5 KPNA1	2.91e-04	9	100	2	9463369
Pubmed	Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import.	KPNA5 KPNA1	2.91e-04	9	100	2	12414950
Pubmed	14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1).	KPNA5 KPNA1	2.91e-04	9	100	2	15057270
Pubmed	Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein.	KPNA5 KPNA1	2.91e-04	9	100	2	10366569
Pubmed	HIV-1 nuclear import: in search of a leader.	KPNA5 KPNA1	2.91e-04	9	100	2	9366553
Pubmed	Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex.	KPNA5 KPNA1	2.91e-04	9	100	2	10860744
Pubmed	Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging.	RAP1B MTOR	2.91e-04	9	100	2	24337580
Pubmed	Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import.	KPNA5 KPNA1	2.91e-04	9	100	2	12368302
Pubmed	Transportin 3 and importin α are required for effective nuclear import of HIV-1 integrase in virus-infected cells.	KPNA5 KPNA1	2.91e-04	9	100	2	21326825
Pubmed	Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses.	KPNA5 KPNA1	2.91e-04	9	100	2	11035935
Pubmed	HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway.	KPNA5 KPNA1	2.91e-04	9	100	2	9275210
Pubmed	Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.	ADAMTS1 ADAMTS9	2.91e-04	9	100	2	23095891
Pubmed	The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA.	KPNA5 KPNA1	2.91e-04	9	100	2	10888652
Pubmed	Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.	KPNA5 KPNA1	2.91e-04	9	100	2	1631159
Pubmed	A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.	KPNA5 KPNA1	2.91e-04	9	100	2	8105392
Pubmed	Characterization of the nuclear import pathway for HIV-1 integrase.	KPNA5 KPNA1	2.91e-04	9	100	2	11278458
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	ADAMTS1 RUNX2 NEDD1 THBS4 PRG2	3.62e-04	210	100	5	16537572
Pubmed	HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase.	KPNA5 KPNA1	3.63e-04	10	100	2	9282826
Pubmed	CEP192 interacts physically and functionally with the K63-deubiquitinase CYLD to promote mitotic spindle assembly.	CEP192 NEDD1	3.63e-04	10	100	2	22895009
Pubmed	Fbxo45 inhibits calcium-sensitive proteolysis of N-cadherin and promotes neuronal differentiation.	MYCBP2 FBXW5	4.43e-04	11	100	2	25143387
Pubmed	The HIV-1 passage from cytoplasm to nucleus: the process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration.	KPNA5 KPNA1	4.43e-04	11	100	2	22509482
Pubmed	HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr.	KPNA5 KPNA1	4.43e-04	11	100	2	9562972
Pubmed	Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.	KPNA5 KPNA1	5.30e-04	12	100	2	7494303
Pubmed	Acetylation-dependent regulation of Skp2 function.	KPNA5 KPNA1	5.30e-04	12	100	2	22770219
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS1 ADAMTS9 ADAMTS18	3.58e-05	19	62	3	50
GeneFamily	Adhesion G protein-coupled receptors, subfamily G	ADGRG4 ADGRG6	2.40e-04	7	62	2	917
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	KPNA5 ARMC2 KPNA1	4.30e-04	43	62	3	409
GeneFamily	Armadillo repeat containing\|Importins	KPNA5 KPNA1	1.71e-03	18	62	2	596
GeneFamily	WD repeat domain containing	IFT172 NEDD1 WDR47 TBC1D31 FBXW5	2.03e-03	262	62	5	362
ToppCell	Int-URO-Lymphocyte-T_NK-CD8_TCM\|Int-URO / Disease, Lineage and Cell Type	IL32 MID2 TMEM204 DDIT4L VWDE CD6	1.46e-06	158	99	6	edcc5a26d4571b179f3ae538fed23b661e4677dd
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMEM204 OR51E1 FADS3 ADAMTS9 ADAMTS18 ADGRF5	2.91e-06	178	99	6	360d7a987f91d6d721487a921824057ec31a7332
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IL32 TMEM204 RUNX2 LINS1 PGAP1 ALK	3.31e-06	182	99	6	3a3ed195c15d33d46a2f395cb93018e4bba28353
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ATP6V0A1 ADAMTS1 PKD1L1 ATP10D NUP155 PLXNC1	3.64e-06	185	99	6	e06a784a297f357f3f8e761c24fa70722048ab42
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 RUNX2 KLRK1 LINS1 DIP2A CD6	4.11e-06	189	99	6	e9df7ecd36bee1fedce23bb188c68a94fa60462c
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PKD1L1 MCMDC2 CSMD3 QPRT C1QA	4.34e-06	108	99	5	695ed3f8cf637d767a6d79b0309d5ee82dfd063f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 TMEM204 MCMDC2 RUNX2 KLRK1 CD6	4.64e-06	193	99	6	c3cffafc1d40c3d7cf81034d5c51f1c78f5eb0a9
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	TMEM204 DDIT4L CHRNG THBS4 PLXNC1 SORCS2	4.78e-06	194	99	6	55b97095a7a17a312c616703d291738a0f806339
ToppCell	Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets\|Control_saline / Treatment groups by lineage, cell group, cell type	EPHB2 GALNT10 RAP1B ARMC2 FBXW5 GNAZ	5.53e-06	199	99	6	86d4e5dd3bcc6bafa48fd0211dad39a2456b53be
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TMEM204 ADAMTS1 ECE1 ERVMER34-1 BDKRB2 ADGRF5	5.53e-06	199	99	6	463ba77dc4c85eebb343f29a42c7ac889b0497c9
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / Treatment groups by lineage, cell group, cell type	ADAMTS1 ECE1 BDKRB2 ADGRG6 ADAMTS9 FAM3C	5.69e-06	200	99	6	b036f5e22c95a3b14391785b6e91aa183b9bc9a8
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 RAP1B ADGRG4 KLRK1 DIP2A FBXW5	5.69e-06	200	99	6	2bd8c35484fe6b0bc0f9314216786baaa97d1e95
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Mesoderm\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	KPNA5 GALNT10 IL32 MCMDC2 NYNRIN	1.48e-05	139	99	5	d441c29852c28928ecb696b4b95e31b30c17116b
ToppCell	facs-Lung-EPCAM-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ECE1 BDKRB2 C21orf140 ADAMTS18 SAYSD1	2.58e-05	156	99	5	bb64bf520cb74897a01c64924a85a1550df2b801
ToppCell	COVID-19_Moderate-multiplets\|World / disease group, cell group and cell class	IL32 ADGRG6 DIP2A PGAP1 PARP15	2.58e-05	156	99	5	afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCell	facs-Marrow-KLS-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D30 TEX14 QPRT SLC6A20 GNAZ	2.67e-05	157	99	5	3c6be6995c00c4cadbd209c66bf9a87c8c238652
ToppCell	facs-Marrow-KLS-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D30 TEX14 QPRT SLC6A20 GNAZ	2.67e-05	157	99	5	662d5026e0e4249029fc6f3abc771d775d7bc3bb
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 MID2 TMEM204 CD6 DIP2C	3.01e-05	161	99	5	580153e131247e6ec12a1a920f050a0a763e7e87
ToppCell	facs-Lung-EPCAM-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ECE1 BDKRB2 C21orf140 ADAMTS18 SAYSD1	3.10e-05	162	99	5	1f1b93394b1f27cbb76b369c19b9313609edd577
ToppCell	droplet-Lung-nan-21m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLRK1 SLC2A10 TBC1D31 SLC6A20 HASPIN	3.48e-05	166	99	5	21ba5fd755c0fb31ada42a1b5d60bede0153323d
ToppCell	mild_COVID-19-HSPC\|mild_COVID-19 / disease group, cell group and cell class (v2)	MCMDC2 C1orf167 VWDE ADGRG6 ALK	3.68e-05	168	99	5	90b33962adb77d8326dee403712118398b4d1315
ToppCell	mild_COVID-19-HSPC\|World / disease group, cell group and cell class (v2)	MCMDC2 C1orf167 VWDE ADGRG6 ALK	3.90e-05	170	99	5	85c476e0bc496445e868a88849960598d97bdea2
ToppCell	facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB2 TRPC1 RUNX2 FADS3 FAM3C	4.24e-05	173	99	5	ca3d2a9562734f76127e3e7d54c10b63e95141bb
ToppCell	facs-Marrow-T-cells-24m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB2 TRPC1 RUNX2 FADS3 FAM3C	4.24e-05	173	99	5	19a9e10885173d7712996be8660a3a5a7a9aa39f
ToppCell	Nasal_Brush-Epithelial-Basal_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	IL32 TMEM204 ADAMTS1 CSMD3 ADAMTS18	4.60e-05	176	99	5	fc5787946f5a10056d326d070620575ae4081836
ToppCell	Nasal_Brush-Epithelial-Basal_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	IL32 TMEM204 ADAMTS1 CSMD3 ADAMTS18	4.60e-05	176	99	5	5daaba0853afe7d20d4635169ccd4f96e735b938
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TMEM204 ECE1 OR51E1 ADAMTS18 ADGRF5	5.12e-05	180	99	5	64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM204 MYCBP2 PLXNC1 NYNRIN ADGRF5	5.12e-05	180	99	5	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM204 MYCBP2 PLXNC1 NYNRIN ADGRF5	5.12e-05	180	99	5	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAMTS1 ECE1 ADAMTS9 PGAP1 DIP2C	5.39e-05	182	99	5	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR21 ECE1 ADGRG6 FADS3 FAM3C	5.39e-05	182	99	5	aa113a0d2c1d28bda24cbb1221afd21b5628dc6d
ToppCell	COVID-19_Moderate-HSPC\|World / disease group, cell group and cell class	VWDE ADGRG6 SLC2A10 PRG2 NYNRIN	5.68e-05	184	99	5	ccc93babe1fcdeb66b78e1d8414357877a7c45bd
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM204 ADAMTS1 ADAMTS9 PLXNC1 ADGRF5	5.82e-05	185	99	5	742350093d90f96735dc73e3360cdd749bae63fd
ToppCell	droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR21 ECE1 ADGRG6 FADS3 FAM3C	5.82e-05	185	99	5	eeb6f55a6f79adf80247baa2c4b0df44553557ad
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 STRIP1 ADGRG6 HASPIN ANO3	5.82e-05	185	99	5	554c5d812197fbf66bf279fcc953277e926ade15
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAMTS1 ECE1 ADAMTS9 PGAP1 DIP2C	5.82e-05	185	99	5	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	OR51E1 ADAMTS9 ALPK3 ADAMTS18 ADGRF5	5.98e-05	186	99	5	e8ead5634686ebaa6a230eea69795d923ce9939d
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPR21 ADGRG6 FADS3 NYNRIN FAM3C	5.98e-05	186	99	5	ffbc78058be8f0dc2e0335cc4c3195a636d17721
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPR21 ADGRG6 FADS3 NYNRIN FAM3C	5.98e-05	186	99	5	ed924852cd7132c8f6703522037dc22bd2c83193
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS1 DDIT4L ADGRG6 FADS3 ADAMTS9	6.13e-05	187	99	5	9aa411ae9b5a923378a5daebb8bb2fc2613f2510
ToppCell	Endothelial-A-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	IL32 TMEM204 ADAMTS1 ECE1 ADAMTS9	6.13e-05	187	99	5	febe0b99a6a815ce687160a0e7af55228b1d5beb
ToppCell	facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPR21 ECE1 ADGRG6 FADS3 FAM3C	6.13e-05	187	99	5	7170694a1b86fe8d84d96c880ffe57af09bdc026
ToppCell	facs-Heart-RA-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS1 ECE1 ADGRG6 PLXNC1 ADGRF5	6.29e-05	188	99	5	4ddb11a90bf3baa7237bde304db44dfcc56aed52
ToppCell	facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS1 ECE1 ADGRG6 PLXNC1 ADGRF5	6.29e-05	188	99	5	e47e66906922d5c69b1aafe28face0787d3fc563
ToppCell	facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TMEM204 B3GNT3 ECE1 ADAMTS9 ADGRF5	6.44e-05	189	99	5	ecbe079606406f47d4fc97fe1670790dda8e10de
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR21 ECE1 ADGRG6 FAM3C ADGRF5	6.44e-05	189	99	5	9da012fdfa9a8d488cab710a463a1d70e89f990c
ToppCell	IPF-Epithelial-Aberrant_Basaloid\|Epithelial / Disease state, Lineage and Cell class	EPHB2 GALNT10 IL32 FADS3 ADAMTS9	6.44e-05	189	99	5	4178be3292ff4a8a1d8098f638d4b8d15164d2c6
ToppCell	facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TMEM204 B3GNT3 ECE1 ADAMTS9 ADGRF5	6.44e-05	189	99	5	e830fa0ddc3dccfaf9e88e8c416ed6aab12e3e3f
ToppCell	facs-Trachea-18m-Endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TMEM204 B3GNT3 ECE1 ADAMTS9 ADGRF5	6.44e-05	189	99	5	f635f3f13bced3bcf796cf55723a2df851f973fe
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPR21 ADGRG6 FADS3 NYNRIN FAM3C	6.61e-05	190	99	5	3b9abc25b17e7295356ded57ff2ca519fa9f2686
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR21 ECE1 ADGRG6 FAM3C ADGRF5	6.77e-05	191	99	5	3307dbccadb09c62b0e1c0235ec89bb294d748c3
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS1 ECE1 ADGRG6 NYNRIN ADGRF5	6.77e-05	191	99	5	9fc674a58f20b47255e4457d5195c8cff17b0414
ToppCell	facs-Lung-3m-Endothelial-arterial_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPR21 ECE1 ADGRG6 FADS3 FAM3C	6.77e-05	191	99	5	6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c
ToppCell	facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPR21 ECE1 ADGRG6 FADS3 FAM3C	6.77e-05	191	99	5	482db995930346be69072ace2fd78fd453e97fb5
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ADGRG6 OR51E1 ALPK3 ADAMTS18 ADGRF5	6.77e-05	191	99	5	dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b
ToppCell	droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS1 ECE1 ADGRG6 NYNRIN ADGRF5	6.77e-05	191	99	5	c379a499dabf3c9ed80f47adbb2d949821c5b053
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS1 ECE1 BDKRB2 OR51E1 ADAMTS9	6.94e-05	192	99	5	c3dda7c48732b0b8bde36de282d64192f5e9b98f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 TMEM204 RUNX2 KLRK1 CD6	7.11e-05	193	99	5	95f5611dd9583f339b7c9f52bb478af204fb89ad
ToppCell	remission\|World / disease stage, cell group and cell class	IL32 TMEM204 KLRK1 LINS1 CD6	7.11e-05	193	99	5	86cfd0c230ba96a43d343216935952fff6a5254e
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	GALNT10 IL32 KLRK1 CD6 PARP15	7.11e-05	193	99	5	00349d176fb6a46cbcc99c41d975651b6e9aaad4
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	ADAMTS1 ECE1 ADGRG6 ADAMTS9 ADGRF5	7.29e-05	194	99	5	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	10x5'v1-week_17-19-Endothelial\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ADGRG6 OR51E1 ADAMTS9 ALPK3 ADGRF5	7.29e-05	194	99	5	e141beafc9252e5d8c949252bfab53e127c881dc
ToppCell	10x5'v1-week_12-13-Lymphocytic_T\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	IL32 TMEM204 LINS1 CD6 TRAV22	7.29e-05	194	99	5	4abc925820d23793d6ebf83fd7df8e75b32f09b4
ToppCell	10x5'v1-week_12-13-Lymphocytic_T-T_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	IL32 TMEM204 LINS1 CD6 TRAV22	7.29e-05	194	99	5	b1ed9b7ea9298dc3ce900a2c6b0a2ca6412f1f5f
ToppCell	10x5'v1-week_17-19-Endothelial-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ADGRG6 OR51E1 ADAMTS9 ALPK3 ADGRF5	7.29e-05	194	99	5	953578102ffc7b612ee8fce45e414750800fef5d
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical\|TCGA-Thryoid / Sample_Type by Project: Shred V9	B3GNT3 RUNX2 ECE1 EHBP1L1 PLXNC1	7.29e-05	194	99	5	b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TMEM204 ADAMTS1 ECE1 ADGRG6 ADGRF5	7.47e-05	195	99	5	4658fb197657d7692ee344ae76b11b0210c418ba
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IL32 TMEM204 ECE1 CD6 PGAP1	7.47e-05	195	99	5	6ddce0cce14f737e45b8f57802c6a8ad07686262
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IL32 TMEM204 ECE1 CD6 PGAP1	7.47e-05	195	99	5	e6212373cc3c6c98f76e104e2ac1afa68965cc5f
ToppCell	Endothelial-A-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	IL32 TMEM204 ADAMTS1 ECE1 ADAMTS9	7.47e-05	195	99	5	c3a0aa34b672c99cb3a2a4e9218412dbd19da3ca
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM204 ADAMTS1 BDKRB2 ADGRG6 ADAMTS9	7.47e-05	195	99	5	53b83e16b350100b1d5791a9c42bd98e37cbc0af
ToppCell	Mild_COVID-19-T/NK-CD4+_T_2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IL32 TMEM204 ECE1 CD6 PGAP1	7.65e-05	196	99	5	e50d03d8428dc4526e4607b6b4e99f0812a0ad31
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TMEM204 ECE1 OR51E1 ADAMTS18 ADGRF5	7.65e-05	196	99	5	73f029d2b276776d6c24356b14c6592c9cb74bd5
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IL32 TMEM204 ECE1 CD6 PGAP1	7.84e-05	197	99	5	0b4fdf0131dd67a86ee3209fa66db0ca2e01a10e
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ADGRG6 ADAMTS9 ALPK3 ADAMTS18 ADGRF5	7.84e-05	197	99	5	4e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LRRC66 KLRK1 DIP2A PGAP1 PARP15	7.84e-05	197	99	5	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 KLRK1 DIP2A CD6 FBXW5	7.84e-05	197	99	5	8e41e6cda38eace961cb1a56f4df24468c66b956
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERCC6L PIEZO1 TEX15 ADGRG6 ADAMTS9	7.84e-05	197	99	5	76b61e60a757e58b465569538e632d6d9953e89a
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IL32 ECE1 KLRK1 CD6 PGAP1	7.84e-05	197	99	5	927bf36bad3bcb7346c13b660777c1c0de7dc322
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD3-NKT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IL32 BTBD17 CD6 TRAV22 PARP15	7.84e-05	197	99	5	e2e7bc8e6c45c987d91cc3ee504fc5af130a69fe
ToppCell	Mild-Lymphoid-T-CCR7+_T\|Mild / Condition, Lineage, Cell class and cell subclass	IL32 TMEM204 ECE1 CD6 PGAP1	7.84e-05	197	99	5	f23bd8f6ad011730699a5bb7211cd0feeaebc42b
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD3\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IL32 BTBD17 CD6 TRAV22 PARP15	7.84e-05	197	99	5	46f82cce0f3c3ddb087953949e76aae19dc8bbf3
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IL32 TMEM204 ECE1 CD6 PGAP1	7.84e-05	197	99	5	b3876076684781fb8384117f2cf367d828985986
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IL32 ECE1 KLRK1 CD6 PGAP1	7.84e-05	197	99	5	3e09158507df08c08e08613ce23617206280c911
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS1 OR51E1 FADS3 ADAMTS9 ALPK3	8.03e-05	198	99	5	7dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCell	10x5'v1-week_12-13-Endothelial-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TMEM204 ADAMTS9 ALPK3 ADAMTS18 ADGRF5	8.03e-05	198	99	5	122215d9288533ad03562cf777e846504863df9a
ToppCell	Transverse-B_cell-B_cell_IgG_Plasma\|Transverse / Region, Cell class and subclass	TBC1D30 TEX14 ERVMER34-1 QPRT FAM3C	8.03e-05	198	99	5	a4ece1fe3d15acfde0e6ff14cddb3a3d16f61ce0
ToppCell	10x5'v1-week_12-13-Endothelial\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TMEM204 ADAMTS9 ALPK3 ADAMTS18 ADGRF5	8.03e-05	198	99	5	307dd09e6bc820a148f3000f18dae7aedba4be0b
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IL32 TMEM204 ECE1 CD6 PGAP1	8.03e-05	198	99	5	6c375fc7e53ed7b7b0feba459958d177a65f7272
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	TMEM204 ADAMTS1 ECE1 ADGRG6 ADAMTS9	8.03e-05	198	99	5	531b0f88c95f813e3914c96749f591e80ca321d0
ToppCell	Transverse-(2)_B_cell-(21)_B_cell_IgG_Plasma\|Transverse / shred on region, Cell_type, and subtype	TBC1D30 TEX14 ERVMER34-1 QPRT FAM3C	8.03e-05	198	99	5	d6052b5a44246798e90f4779cd940ffac7539fcd
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRPC1 DDIT4L CSMD3 WDR47 THBS4	8.22e-05	199	99	5	fbec5c034576cb1adaf05f6f97cc5525d19e0c1b
ToppCell	Non-neuronal-Postmitotic-Endothelial\|World / Primary Cells by Cluster	IL32 TMEM204 ECE1 ALPK3 ADGRF5	8.22e-05	199	99	5	b9763ac9857a60db6f1f104fe1e9ea2266cf931b
ToppCell	Non-neuronal-Postmitotic-Endothelial-Endothelial-24\|World / Primary Cells by Cluster	IL32 TMEM204 ECE1 ALPK3 ADGRF5	8.22e-05	199	99	5	0b4edf3e359749827ef978a77b5267ddde732d71
ToppCell	Non-neuronal-Postmitotic-Endothelial-Endothelial\|World / Primary Cells by Cluster	IL32 TMEM204 ECE1 ALPK3 ADGRF5	8.22e-05	199	99	5	9e01eee126247a0696c71b019f855a8a41a0ede3
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 ADGRG6 ADAMTS9 ADAMTS18 ADGRF5	8.22e-05	199	99	5	0d63da0afa93741c37609d879941de202d9ac86c
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-tip_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	IL32 TMEM204 ADAMTS9 ALPK3 ADGRF5	8.22e-05	199	99	5	1c69395c9305b6ecb0a826d46c8e8ec95795ad6d
ToppCell	Tracheal-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS1 OR51E1 FADS3 ADGRF5 ANO3	8.22e-05	199	99	5	cefc3b50f65e95da850e4720c7b44bf584073491
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IL32 TMEM204 ECE1 CD6 PGAP1	8.22e-05	199	99	5	ee29b65a3c545a9d19c2fbcc0364ee235dd018dc
ToppCell	Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PDE1B ADAMTS1 OR51E1 FADS3 ANO3	8.22e-05	199	99	5	aaa460c389cd6d38a13ba1a446f91a94f9573ad8
Drug	Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A	KPNA5 TBC1D30 PHF8 ALPK3 SAYSD1 MFSD13A ALK	1.83e-05	196	95	7	3726_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	EPHB2 KPNA5 MID2 TEX14 ATP10D TTLL4 SAYSD1	1.83e-05	196	95	7	5276_DN
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ZNF219 TBC1D30 B3GNT3 EHBP1L1 CD6 PLXNC1 SAYSD1	2.02e-05	199	95	7	2289_DN
Drug	Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A	EPHB2 ZNF219 B3GNT3 PLXNC1 PGAP1 SAYSD1 ALK	2.02e-05	199	95	7	6675_DN
Drug	Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A	EPHB2 ECE1 ATP10D PLXNC1 NYNRIN PGAP1 ALK	2.02e-05	199	95	7	1531_UP
Disease	complement C1q subcomponent subunit C measurement	EPHB2 C1QA	4.73e-04	10	97	2	EFO_0801492
Disease	pulmonary hypertension (implicated_via_orthology)	ECE1 BDKRB2 MTOR	7.56e-04	54	97	3	DOID:6432 (implicated_via_orthology)
Disease	early cardiac repolarization measurement	KPNA5 MYCBP2	9.49e-04	14	97	2	EFO_0004885
Disease	lipid metabolism disorder (implicated_via_orthology)	FADS2B FADS3	1.09e-03	15	97	2	DOID:3146 (implicated_via_orthology)
Disease	amygdala volume change measurement	PKD1L1 SPATA31C1	1.25e-03	16	97	2	EFO_0021490
Disease	portal hypertension (implicated_via_orthology)	BDKRB2 MTOR	1.76e-03	19	97	2	DOID:10762 (implicated_via_orthology)
Disease	atrophic macular degeneration	TEX15 PRG2	3.05e-03	25	97	2	EFO_1001492

Protein segments in the cluster

Peptide	Gene	Start	Entry
WFIINNRNEFCLQSI	C21orf140	191	B9A014
TISNNFDWLFGETLC	BDKRB2	116	P30411
LQALQLAVFFLWCQQ	C1orf167	621	Q5SNV9
RFQLQCDWNTSDFSI	ERVK-19	546	O71037
LTCIANSVNTASWDF	CSMD3	216	Q7Z407
FTFQVLSQWEICLSI	C1QA	161	P02745
NLVFLINSWLSSFQK	ADGRG4	2791	Q8IZF6
WQNCSLIFQSQTYST	CHRNG	161	P07510
FAESFEQLCLVWNNS	ADGRG6	246	Q86SQ4
VCKTLWNFSENITNA	ARMC2	781	Q8NEN0
ESCLQFLAWNLSAVA	BTBD17	186	A6NE02
LWCQFFNILSDSVLT	ALPK3	1496	Q96L96
WTFVNDSLCTTLSLQ	CCNK	186	O75909
LTLVFKQENCSWTSF	DDIT4L	136	Q96D03
SLQKQFLELTSWCQA	ATP10D	1011	Q9P241
ADQSLNSFCQWQSAL	ADAMTS18	361	Q8TE60
WQFATSAAAVCINFI	ANO3	591	Q9BYT9
NCTLQFEAAWALTNI	KPNA5	141	O15131
RQWNNCAFLESSAKS	RAP1B	136	P61224
VTSNAALTLRNFCNW	ADAMTS1	321	Q9UHI8
SWRFNNSNLCSQSLA	CD6	341	P30203
TSITNLGFRDNWVFC	FAM3C	171	Q92520
CQAFLDEFTNWSRIN	PARP15	256	Q460N3
LSNSWIAFCQKNLSE	LINS1	166	Q8NG48
SSCWKFTAILANIFA	MCMDC2	296	Q4G0Z9
GISSICWSSNNNFLV	NEDD1	36	Q8NHV4
CNSFNWAANLFISLS	SLC2A10	451	O95528
NTCNPSSLTQQWLFE	GALNT10	576	Q86SR1
VFRTLSILTNQSNCW	ERVMER34-1	31	Q9H9K5
VCNVFESSQNNWLRT	EPHB2	61	P29323
DITSCSVLWLNNAFQ	FBXW5	211	Q969U6
WNLSDRFNFTNCSSL	PLXNC1	581	O60486
IFWFNSTTIQFDACL	OR51E1	86	Q8TCB6
LDLWCFDVFSLNQAA	PDE1B	161	Q01064
VTIWSAVFLNSLFNQ	KLRK1	71	P26718
LAIAAFSNWTCNFIV	SLC2A2	436	P11168
FSNWTCNFIVALCFQ	SLC2A2	441	P11168
NFTTSWRNGLAFCAI	EHBP1L1	1061	Q8N3D4
DAIFTQLNCQVSWFL	QPRT	61	Q15274
WQCDDSVAVFQNFIS	LRRC66	256	Q68CR7
FIVQFLEQQVCTLNW	NUP155	1266	O75694
CNKFIQTSAVTCLQW	IFT172	106	Q9UG01
WLTTQVLATCNTESF	FADS2B	396	A8MWK0
LVRSLQTFSQAWFTC	PRG2	111	P13727
VAFCFWLLSNVLLST	DUOXA2	186	Q1HG44
ISFNAQTTLKNFCQW	ADAMTS9	356	Q9P2N4
WTQTCNTLFFIFSTI	CERS3	256	Q8IU89
AVQALWKQFQSFCCS	IL32	186	P24001
WKQFQSFCCSLSELF	IL32	191	P24001
ESLRLFDSICNNNWF	GNAZ	246	P19086
FDSICNNNWFINTSL	GNAZ	251	P19086
WSISSCDAFLNVFQS	DIP2C	626	Q9Y2E4
LFLQWQETRCANASF	B3GNT3	191	Q9Y2A9
QNVCFWTKTRASFSF	HASPIN	376	Q8TF76
INANAVAWRCFTFSK	CEP192	1536	Q8TEP8
TNNQLFFLGFAQVWC	ECE1	701	P42892
WSISSCDAFLNVFQS	DIP2A	641	Q14689
SFLTTWLAISNSFCN	GPR21	286	Q99679
AAFILAISQAQSWCL	FADS3	166	Q9Y5Q0
WRTQAVVLAQCNFSL	SLC22A13	221	Q9Y226
ITCALLQLFTWSQFT	MFSD13A	476	Q14CX5
SALVNASVAFECWIN	PKD1L1	601	Q8TDX9
QNNLQELWSLFDFAC	ERCC6L	261	Q2NKX8
SLHLAWLLSQACFNF	NYNRIN	376	Q9P2P1
QISSDNCFLQWGFKT	MTERF3	46	Q96E29
CFLEAIWSNIFSLNL	PLA2G4D	521	Q86XP0
DLFNAAFVSCWSELN	MTOR	1316	P42345
LFSTVTPCQQNFFWD	RUNX2	6	Q13950
FASCWNSQEFIQTLS	TEX14	1241	Q8IWB6
NTILSCFKDNSIFAW	TBC1D31	181	Q96DN5
CTLQFESAWVLTNIA	KPNA1	141	P52294
STNKCSANFWFNPLS	SORCS2	721	Q96PQ0
DSNQFCWRNLFSCIN	STRIP1	656	Q5VSL9
AFNWLLCNVIQTTSL	MYCBP2	3576	O75592
LDTNSWIFACINSTS	PGAP1	391	Q75T13
TWCIFNSSVQQDHLS	SPATA31C1	301	P0DKV0
ANSSCVRNAFWLQIT	RIG	46	Q13278
PLWANSLQFVFACIS	SLC6A20	6	Q9NP91
ALQSSFTCWNGTVLQ	ALK	436	Q9UM73
ETKCVFWNFRLANNT	ADGRF5	951	Q8IZF2
ISLLNCSNATLWLSF	SLC49A3	36	Q6UXD7
FVSQSNCQQFLNTVW	TRPC1	321	P48995
RQWNNCAFLESSAKS	nan	136	A6NIZ1
LGVFCFSQENIIWSN	THBS4	921	P35443
WQFLFSTTKDCCLFQ	VWDE	116	Q8N2E2
SWLQNLPSSVFSCAF	WDR47	246	O94967
FANNSSLWFTSCLSI	TAS2R9	91	Q9NYW1
LCSAQVAAWFFATLA	TMEM102	261	Q8N9M5
NTCWFSAVIQSLFNL	USP25	176	Q9UHP3
TWSTCAFTIQAIENL	UBR1	1321	Q8IWV7
NVFTMQWFLTLFATC	TBC1D30	426	Q9Y2I9
QWFLTLFATCLPNQT	TBC1D30	431	Q9Y2I9
SCWDQSFLTNITFLK	SAYSD1	91	Q9NPB0
IWNIATNKLTFLNSF	ATP6V0A1	521	Q93050
AINFSCWSAVKLQLS	XKR3	316	Q5GH77
NNVAAFTSNWVCQTL	TMEM204	21	Q9BSN7
NLTLFECWSSSSNQN	PHF8	311	Q9UPP1
SDFLLLLCASQQWQV	PIEZO1	1101	Q92508
LFCNSQLSNDIWLNV	TEX15	456	Q9BXT5
NASSWVFSRCNSNFV	MID2	621	Q9UJV3
GASNIINNFIICWSF	TMEM217	51	Q8N7C4
GSFELWQVQCAQSFQ	TRIM65	366	Q6PJ69
CQLEQSSFLNPSFQW	TTLL4	356	Q14679
AFALWLQDSTQTLQC	VIRMA	756	Q69YN4
LRCNFSDSVNNLQWF	TRAV22	41	A0A0B4J277
CQVCGQSFTQSWFLK	ZNF219	276	Q9P2Y4